CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer.

Yun-Shuai WangYu KouRen-Tao ZhuBao-Wei HanChao-Hui LiHuang-Jian WangHui-Bin WuTian-Ming XiaXiang-Ming Che

Published in: Disease markers (2022)

These results indicated CDX2 as prognostic biomarkers involved in immunotherapy response for CRC. CDX2 loss promotes metastasis in CRC through a CDX2-dependent mechanism.

Keyphrases

epithelial mesenchymal transition
signaling pathway